SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-22-013879
Filing Date
2022-04-07
Accepted
2022-04-07 17:01:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A vktx-defa14a_20220524.htm DEFA14A 10111
2 GRAPHIC gbckx4k3fhgy000001.jpg GRAPHIC 1637990
  Complete submission text file 0001564590-22-013879.txt   2266740
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37355 | Film No.: 22814557
SIC: 2834 Pharmaceutical Preparations